Advisory Board

Endeavour Capital is fortunate to have access to the services of a world-class advisory board during the evaluation of potential investments and the subsequent growth phase of portfolio companies. Drawing on their international resources, networks and considerable experience, the advisory board adds considerable value in the development of successful portfolio companies.

David Teece

Professor David Teece is an authority on matters of technological change and organizational structure, particularly as it relates to competition policy and intellectual property. He is the Mitsubishi Bank Professor at the Haas School of Business at the University of California, Berkeley, where he also directs the Institute of Management, Innovation and Organization, and is Chairman of the Consortium for Research on Telecommunications Policy.

Professor Teece has a Ph.D. in Economics from the University of Pennsylvania and a MBA from Wharton and has held teaching and research positions at Stanford University and Oxford University. He has testified before Congress on regulatory policy and competition policy, is author of over 100 books and articles, and is the editor of Industrial & Corporate Change (Oxford University Press).

He has also testified before judges, juries, arbitrators, and tribunals in the U.S. and abroad, both on liability and complex valuation and damage issues. Professor Teece has been Chairman of LECG since 1988. He is also a Director of the Atlas Family of Mutual Funds and I-CAP.

Robert Genieser

Mr Genieser joined Vertex as the Managing Director for Europe in 2002. His main focus is to oversee Vertex offices in London, Copenhagen and Marseille, coordinating a team of 15 investment professionals. He also serves as a Partner in Vertex Management Israel.

Prior to joining Vertex, Mr Genieser was a Managing Director of Hambrecht & Quist, which he joined in 1996 in their San Francisco office. While in Silicon Valley, Mr Genieser managed the Firm's wireless, optical and communications software practices. In this capacity, he led the Firm's investments into Chromatis (acquired by Lucent), Paragon Software (acquired by Openwave) and Wavtrace (acquired by Harris). In addition to his investing activities, Mr Genieser executed the IPOs of Portal Software, ONI systems, Corvis, Openwave and INET, amongst others. In the M&A field, Mr Genieser assisted VisionTech on its sale to Broadcom, I-compression on its sale to Globespan, Herrmann Technology on its sale to Lucent, Terayon on its acquisition of Telegate and MoreCom on its sale to Liberate.

Shortly after Hambrecht & Quist's merger with JP Morgan at the end of 2000, Mr Genieser moved to London to run the company's emerging technology practice for Europe and Israel.

Earlier in his career, Mr Genieser worked as a consultant for Bain & Company in San Francisco, where he focused on the telecommunications industry. Prior to receiving his MBA, he worked for Morgan Stanley in both New York and Hong Kong as a member of the corporate restructuring group.

Mr Genieser received an AB (cum Laude) and an MBA from Harvard University.

Shirley Leitch

Professor Leitch was appointed Dean of Commerce at the University of Wollongong in Australia in 2006. From 2002-2006, she was Pro Vice Chancellor of Public Affairs at the University of Waikato where she also held a personal chair in corporate communication. While at the University of Waikato, Professor Leitch was the deputy leader of a major Foundation for Research, Science and Technology project investigating sustainable biotechnology.

Her international standing as a researcher has been recognised through the award of an 'A' grade in both rounds of the New Zealand Performance Based Research Fund.
Professor Leitch earned her PhD in 1986 from the University of Auckland and has also held academic positions at Auckland, Victoria University of Wellington and Massey University, and was an Adjunct Research Professor at the University of Technology, Sydney. Her research agenda has focused on public communication, with a particular emphasis on science-society engagement and on effecting societal change. Professor Leitch was the research leader of the Growth Culture sub-group of the New Zealand Prime Minister's think tank, the Growth and Innovation Advisory Board. She was also a Ministerial appointee on the government's Ecommerce Action Team, which drove the formation and dissemination of New Zealand's ecommerce strategy.

Her research has a strong interdisciplinary character and has appeared in leading management, communication and marketing journals including European Journal of Marketing, Human Relations, Organization Studies, Science and Public Policy, Discourse Studies, Public Relations Review, Australian Journal of Communication, International Studies in Management and Organization, and the Journal of Communication Management.

Dr Sue Foden

Dr Sue Foden holds a number of non executive directorships with both public and private companies and public funding bodies in the biotech and healthcare field. Prior to this Sue held positions in VC, technology transfer and UK biotech.
From 2000 to 2003, she was an Investor Director with the London- based VC firm Merlin Biosciences Ltd. From 1987 to 2000 she was CEO of the Technology transfer company, CRCT, and from 1998 to 2000 also of Cancer Research Ventures [CRV].
From 1983 to 1987 Sue headed up the academic liaison function at what was then Celltech Ltd, dealing with some of the earliest tech transfer deals in the UK and the precedents that these set. Sue studied biochemistry at the Univ of Oxford from where she obtained her MA and DPhil degrees.

People
Read more about our
Management Team >>
Associates >>

Head office contact details Endeavour Capital
Level Five Wakefield House
90 The Terrace
Wellington
New Zealand
Phone +64 4 499 5140

For further contact details, click here >>